Click here to close now.


News Feed Item

Epilepsy Foundation Presents Lifetime Accelerator Award to H. Steven White, Ph.D., for Contributions to the Field of Epilepsy and Seizures

Dr. White to Be Honored at 4th Biennial Epilepsy Pipeline Conference 2014 in San Francisco June 5-7

LANDOVER, MD--(Marketwired - May 29, 2014) - The Epilepsy Foundation announced today that H. Steven White, Ph.D., professor of pharmacology and toxicology and principal investigator of the National Institutes of Health (NIH)-sponsored Anticonvulsant Drug Development Program at the University of Utah College of Pharmacy, has been named the 2014 recipient of the Epilepsy Foundation's Lifetime Accelerator Award, in recognition of his commitment and pioneering contributions to the field of epilepsy and seizures. Dr. White will be honored at the 4th Biennial Epilepsy Pipeline Conference 2014, being held June 5-7, 2014, at the Hyatt Regency San Francisco.

A leader in translational research in anticonvulsant drug therapies, Dr. White is well-recognized for his scientific leadership of the University of Utah NIH-sponsored Anticonvulsant Drug Development (ADD) Program, founded in 1975 by the late Ewart A. Swinyard in collaboration with the National Institutes of Neurological Disorders and Stroke (NINDS), NIH. Dr. White's career in antiepileptic drug discovery began in 1986 as the senior scientist of the ADD Program. Over the three decades that mark Dr. White's research in the field, this program has played a crucial role in the early identification and characterization of thousands of novel anticonvulsant medications using established seizure and epilepsy models. Dr. White's laboratory has identified and characterized the anticonvulsant profile and potential mechanism of action for established and new anti-epilepsy agents. Notably, the efforts of the faculty, staff and students of this program, which Dr. White has directed since 2001, have since its establishment in 1975 contributed to the successful development of multiple new therapeutics, including felbamate, rufinamide, topiramate, retigabine and lacosamide.

"On behalf of the Epilepsy Foundation and many clinicians treating seizure conditions today, we are especially pleased to honor Dr. White with the Lifetime Accelerator Award and to recognize his outstanding contributions in anticonvulsant drug development," said Philip M. Gattone, president and CEO of the Epilepsy Foundation. "We are grateful not only for his steadfast commitment to our mission, but also for his energy and enthusiasm for mentoring the next generation of neuroscientists and epilepsy educators."

"Dr. White has been a force behind many of the therapeutics used in treatment today. He is truly dedicated to finding therapies that will make a difference to patients through development of new animal models," said Jacqueline A. French, M.D., director of the Epilepsy Study Consortium, and director of clinical trials at NYU's Comprehensive Epilepsy Center. "He has given generously of his free time to collaborate with other researchers and epilepsy organizations and this recognition is well-deserved."

Ongoing translational research in Dr. White's laboratory is focused on the development of novel models of therapy resistant models and understanding the influence of genetics on the pathophysiology, seizure-susceptibility and anti-epileptic drug pharmacology of animal seizure and epilepsy models. Dr. White and his colleagues at Utah and the NINDS are conducting research that may lead to novel therapies for treatment-resistant epilepsy and importantly, disease-modifying therapies with the potential to halt, slow, or prevent the development of epilepsy in susceptible individuals. He is also a scientific co-founder of NeuroAdjuvants, Inc., a Salt Lake City-based biotechnology firm focused on the development of metabolically stable, blood-brain-barrier neuropeptides for the treatment of refractory epilepsy and pain.

Dr. White earned his Ph.D. in Pharmacology in 1984 at the University of Utah and an M.S. in Pharmacology and baccalaureate degree in Pharmacy at Idaho State University. He began his career as a practicing pharmacist and since 1984 has risen through the academic ranks at the University of Utah. On November 18, 2011, Dr. White received an Honorary Doctor of Science from The University of Copenhagen Faculty of Pharmaceutical Sciences, Copenhagen, Denmark. Over the years, Dr. White has been the recipient of significant research funding from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and he and his collaborators have published over 170 original papers pertaining to the mechanism of action and the pharmacology of antiepileptic drugs. In addition to his academic service, Dr. White has served as Research Director of CURE (Citizen's United for Research in Epilepsy), the largest non-governmental provider of epilepsy research funding, since November 2011.

Epilepsy Foundation's Lifetime Accelerator Award
The Lifetime Accelerator Award was established in 2012 to honor physicians, scientists, industry leaders, and other individuals who have demonstrated a lifelong commitment to bringing new therapies to people living with epilepsy. Lifetime Accelerator Award recipients are chosen by an independent committee of global thought leaders and clinical investigators in epilepsy and seizure therapy discovery and development. Harvey Kupferberg, Ph.D., past chief of the Preclinical Pharmacology Section, Epilepsy Branch, NINDS, NIH, was conferred the 2012 Lifetime Accelerator Award, and Henrik Klitgaard, Ph.D., vice president, head CNS research, UCB, received the award in 2013. 

About Epilepsy
When a person has two or more unprovoked seizures, they have epilepsy, which affects more than 2 million people in the United States and 65 million people worldwide. This year, another 150,000 people in our country will be diagnosed with epilepsy. Despite all available treatments, four out of 10 people with epilepsy continue to experience uncontrolled seizures while many more experience less than optimal seizure control.

About the Epilepsy Foundation
The Epilepsy Foundation, a national non-profit with 48 affiliated organizations throughout the United States, has led the fight against seizures since 1968. The Foundation is an unwavering ally for individuals and families impacted by epilepsy and seizures. The mission of the Epilepsy Foundation is to stop seizures and sudden unexpected death in epilepsy (SUDEP), find a cure and overcome the challenges created by epilepsy through efforts including education, advocacy and research to accelerate ideas into therapies. The Foundation works to ensure that people with seizures have the opportunity to live their lives to their fullest potential. For additional information, please visit

"Like" the Epilepsy Foundation on Facebook at and follow us on Twitter at

The following files are available for download:

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
PubNub has announced the release of BLOCKS, a set of customizable microservices that give developers a simple way to add code and deploy features for realtime apps.PubNub BLOCKS executes business logic directly on the data streaming through PubNub’s network without splitting it off to an intermediary server controlled by the customer. This revolutionary approach streamlines app development, reduces endpoint-to-endpoint latency, and allows apps to better leverage the enormous scalability of PubNu...
Growth hacking is common for startups to make unheard-of progress in building their business. Career Hacks can help Geek Girls and those who support them (yes, that's you too, Dad!) to excel in this typically male-dominated world. Get ready to learn the facts: Is there a bias against women in the tech / developer communities? Why are women 50% of the workforce, but hold only 24% of the STEM or IT positions? Some beginnings of what to do about it! In her Day 2 Keynote at 17th Cloud Expo, San...
Discussions of cloud computing have evolved in recent years from a focus on specific types of cloud, to a world of hybrid cloud, and to a world dominated by the APIs that make today's multi-cloud environments and hybrid clouds possible. In this Power Panel at 17th Cloud Expo, moderated by Conference Chair Roger Strukhoff, panelists addressed the importance of customers being able to use the specific technologies they need, through environments and ecosystems that expose their APIs to make true ...
In his General Session at DevOps Summit, Asaf Yigal, Co-Founder & VP of Product at, explored the value of Kibana 4 for log analysis and provided a hands-on tutorial on how to set up Kibana 4 and get the most out of Apache log files. He examined three use cases: IT operations, business intelligence, and security and compliance. Asaf Yigal is co-founder and VP of Product at log analytics software company In the past, he was co-founder of social-trading platform Currensee, which...
Microservices are a very exciting architectural approach that many organizations are looking to as a way to accelerate innovation. Microservices promise to allow teams to move away from monolithic "ball of mud" systems, but the reality is that, in the vast majority of organizations, different projects and technologies will continue to be developed at different speeds. How to handle the dependencies between these disparate systems with different iteration cycles? Consider the "canoncial problem"...
Culture is the most important ingredient of DevOps. The challenge for most organizations is defining and communicating a vision of beneficial DevOps culture for their organizations, and then facilitating the changes needed to achieve that. Often this comes down to an ability to provide true leadership. As a CIO, are your direct reports IT managers or are they IT leaders? The hard truth is that many IT managers have risen through the ranks based on their technical skills, not their leadership ab...
I recently attended and was a speaker at the 4th International Internet of @ThingsExpo at the Santa Clara Convention Center. I also had the opportunity to attend this event last year and I wrote a blog from that show talking about how the “Enterprise Impact of IoT” was a key theme of last year’s show. I was curious to see if the same theme would still resonate 365 days later and what, if any, changes I would see in the content presented.
Apps and devices shouldn't stop working when there's limited or no network connectivity. Learn how to bring data stored in a cloud database to the edge of the network (and back again) whenever an Internet connection is available. In his session at 17th Cloud Expo, Ben Perlmutter, a Sales Engineer with IBM Cloudant, demonstrated techniques for replicating cloud databases with devices in order to build offline-first mobile or Internet of Things (IoT) apps that can provide a better, faster user e...
Container technology is shaping the future of DevOps and it’s also changing the way organizations think about application development. With the rise of mobile applications in the enterprise, businesses are abandoning year-long development cycles and embracing technologies that enable rapid development and continuous deployment of apps. In his session at DevOps Summit, Kurt Collins, Developer Evangelist at, examined how Docker has evolved into a highly effective tool for application del...
In recent years, at least 40% of companies using cloud applications have experienced data loss. One of the best prevention against cloud data loss is backing up your cloud data. In his General Session at 17th Cloud Expo, Sam McIntyre, Partner Enablement Specialist at eFolder, presented how organizations can use eFolder Cloudfinder to automate backups of cloud application data. He also demonstrated how easy it is to search and restore cloud application data using Cloudfinder.
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York and Silicon Valley. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty ...
Internet of @ThingsExpo, taking place June 7-9, 2016 at Javits Center, New York City and Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with the 18th International @CloudExpo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world and ThingsExpo New York Call for Papers is now open.
The cloud. Like a comic book superhero, there seems to be no problem it can’t fix or cost it can’t slash. Yet making the transition is not always easy and production environments are still largely on premise. Taking some practical and sensible steps to reduce risk can also help provide a basis for a successful cloud transition. A plethora of surveys from the likes of IDG and Gartner show that more than 70 percent of enterprises have deployed at least one or more cloud application or workload. Y...
Cloud computing delivers on-demand resources that provide businesses with flexibility and cost-savings. The challenge in moving workloads to the cloud has been the cost and complexity of ensuring the initial and ongoing security and regulatory (PCI, HIPAA, FFIEC) compliance across private and public clouds. Manual security compliance is slow, prone to human error, and represents over 50% of the cost of managing cloud applications. Determining how to automate cloud security compliance is critical...
As organizations shift towards IT-as-a-service models, the need for managing & protecting data residing across physical, virtual, and now cloud environments grows with it. CommVault can ensure protection & E-Discovery of your data - whether in a private cloud, a Service Provider delivered public cloud, or a hybrid cloud environment – across the heterogeneous enterprise.